Cassady Schiller Wealth Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Cassady Schiller Wealth Management’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$1.09K	Buy	+13	New	+$1.07K	﹤0.01%	770

Other funds holding ITCI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Cassady Schiller Wealth Management's ITCI Position: Q4 2024 in Review

Cassady Schiller Wealth Management opened a new position in Intra-Cellular Therapies Inc. (ITCI) in Q4 2024: 13 shares worth $1.09K. The stake represents ﹤0.01% of the portfolio and ranks #770 among its holdings.

387 funds tracked by Wall St. Rank hold ITCI as of Q4 2024.

Cassady Schiller Wealth Management held 13 shares of Intra-Cellular Therapies Inc. worth $1.09K as of Q4 2024.
Intra-Cellular Therapies Inc. was a new Cassady Schiller Wealth Management position in Q4 2024.
Intra-Cellular Therapies Inc. made up ﹤0.01% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #770 holding.
387 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.